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Objective: The aim of the present study was to investigate the effects of Longdanxiegan formula granule
(LDXGFG), a Chinese traditional medicine on Toll-like receptor (TLR) pathway in recurrent genital herpes.
Materials and Methods: An experimental recurrent genital herpes model was constructed using herpes
guinea pig model. The effect of LDXGFG on expression levels of TLR pathway genes were detected using
real-time polymerase chain reaction. Furthermore, the dendritic cells and Langerhans cells were isolated
and the TLR pathway genes of these cells were assayed after LDXGFG treatment.
Results: The result suggested two different expression patterns of TLR pathway genes in genital herpes
and recurrent genital herpes, including upregulated genes and downregulated genes. TLR1, TLR4, TLR6,
TLR7, TLR8, TLR9, and TLR10 showed a signiﬁcant decrease while, TLR2, TLR3, and TLR5 increased in
genital herpes and recurrent genital herpes guinea pigs. Meanwhile, the downregulated genes in genital
herpes and recurrent genital herpes were stimulated by LDXGFG. By contrast, the upregulated genes
decreased signiﬁcantly after LDXGFG treatment. In both dendritic cells and Langerhans cells, the TLR
pathway genes exhibited same pattern: the LDXGFG corrected the abnormal expression of TLR pathway
genes.
Conclusion: The present results suggest that LDXGFG is an alternative, inexpensive, and lasting-effect
medicine for herpes simplex virus 2 infection.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Genital herpes is a commondisease throughout theworld,which
is caused by herpes simplex virus (HSV) infections [1]. HSV has been
regarded as being able to transmit through mucosal membranes as
well as invading into nerve tissues, which results in prolonging
infection [2]. Two different kinds of HSVdHSV1 and HSV2dare re-
ported in trigeminal ganglia and lumbosacral ganglia, respectively.
Subsequent study suggested that orofacial areas and genital tract
also could be infected by HSV. From 2001, HSV2 infection has
increased sharply and extended around the globe [3]. Since HSV in-
fections have been widely investigated, the antiviral drugs also
develop rapidly. The most common medicines, including acyclovirs and Universities in Hunan
, Hunan University of Chinese
8, China.
bstetrics & Gynecology. Published(ACV), valacyclovir, famciclovir, and penciclovir are used in clinical
therapy [4,5]. Meanwhile, these medicines also have defects: (1) all
the medicines are too expensive and not economic for using in poor
areas; and (2) genital herpes is a prolonged disease and these med-
icines are not persistent. As a result, new therapy strategy to anti-
HSV infection is needed, which would aid to cure this disease,
especially in developing areas.
Humoral and cellular immune responses are observed after HSV
infection [6e8]. In addition, the depression of cellular immune re-
sponses in recurrent genital herpes has been demonstrated in a
guinea pigmodel [9,10]. Meanwhile, the HSV-speciﬁc Tcells also has
been conﬁrmed that plays a crucial role in anti-HSV in the infected
organisms [9]. Th1 type CD4þ Tcells were raised after HSV infection.
In previous studies, it has been conﬁrmed that HSV-speciﬁc anti-
bodies are not sufﬁcient to preventHSV infectionand the consequent
damages in nervous system [11]. Sin et al [12] demonstrated that
interleukin (IL)-12 could be a suitable adjuvant for HSV2 andby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Table 1
The formula of Longdanxiegan formula granules in the present study.
Ingredients Amount (%)
Gentian 14.01
Plantago 14.01
Skullcap 14.01
Gardenia 9.35
Angelica 9.35
Rehmannia 9.35
Alisma 9.35
Radix 9.35
Akebia 5.61
Licorice 5.61
Total 100
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depressed the morbidity and mortality of HSV2. In conclusion,
proinﬂammatory cytokines participate in HSV-infected recurrent
genital herpes.Figure 1. mRNA expression changes of Toll-like receptor (TLR) pathway genes in genital h
reaction. Different letters show signiﬁcant difference between the control and genital herpIn recent years, substantial progress has been made in under-
standing Toll-like receptor (TLR) pathways involved in viral infec-
ted orgasms. HSV1 and HSV2 trigger TLR expression, which was
found to be stimulated by cytokines and chemokines [13]. These
effects could be triggered by T- and B-cell-mediated immunity. TLR
activation leads to lymph node remodeling [14]. Meanwhile, the
innate response serves to affect acquired immune response medi-
ated by TLR recognition [15]. Recent research has shown that TLR
agonists could mediate in prophylactic or therapeutic devices [16].
Thus, new treatment strategies from the perspective of TLR
pathway on HSV infection need to be established.
Chinese medicine provides a new insight in anti-HSV infection
and shows superiority in low prices and natural resources. Long-
danxiegan formula granule (LDXGFG) is one of the most popular
drugs for recurrent genital herpes and shows a great effective [17].
Ten different herbaceous plantsdgentian, plantago, skullcap,
gardenia, angelica, rehmannia, alisma, radix, akebia, and lico-
ricedmake up LDXGFG [18]. This mixture formula granuleerpes and recurrent genital herpes guinea pig in vulva by real-time polymerase chain
es groups (p < 0.05).
Figure 2. Immunohistochemistry assay of Toll-like receptor (TLR)1, TLR9, myeloid differentiation primary response gene 88 (MyD88), and nuclear factor (NF)-kB in genital herpes
and recurrent genital herpes guinea pig. Bar ¼ 50 mm.
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response of cell types needs to be elucidated.
In the present study, we investigate the different expression of
TLR pathway genes after infectionwith HSV2 in female guinea pigs.
We also assayed the expression of TLR pathway genes after LDXGFG
treatment. Dendritic cells (DCs) and Langerhans cells (LCs) were
isolated and the LDXGFG effects on these cells were demonstrated.
These results support the idea that LDXGFG can modulate TLR
pathway to infectious agents in recurrent genital herpes.
Materials and methods
Animals, virus, and drugs
Female Hartley guinea pigs, age 4 weeks (250 ± 20 g) with viral
infection, were obtained from the animal culture center in Hunan
University of Chinese Medicine (Chansha, Hunan). HSV2 strains
clinically isolated from patients in Hunan University of Chinese
Medicine Afﬁliated Hospital (Changsha, Hunan). By DNA
sequencing, we determined that the virus strain is HSV2SAV [19].
ACV was purchased from SigmaeAldrich (St. Louis, MO, USA). The
LDXGFG was purchased from Sanjiu Medical and Pharmaceutical
Co., Ltd. (Shenzhen, China). The formula is in Table 1. The studies
were strictly approved by the Animal Ethical Committee of Hunan
University of Chinese Medicine.
Construction of genital herpes guinea pig model
The guinea pig vulva ﬁrst was cleaned by physiological saline.
After that, each guinea pig was injected of 0.1mL (1% HSV2SAV) into
3e4 cm deep in the vagina. After 1 week, the genital herpes guineapig model was conﬁrmed by polymerase chain reaction (PCR) and
clinical characterization. Based on the clinical characterization of
vaginitis, the disease course of guinea pig was scored from 0 to 6 on
a composite scale: 0, no symptom of infection; 1, few small vesicles
found in vulva; 2, 10e50% of the vulva area covered by vesicles; 3,
50e100% of the vulva area covered by vesicles; 4, 10e50% of the
vulva areawas covered by small ulcers; 5, 50e100% of the vulva area
covered by severe ulcers; and 6, hind limb paralysis or death. As the
following study is long-standing, we used the animals that scored 4
in this study [20]. The recurrent genital herpes model was con-
structed. By cyclophosphamide injection and 5 minutes UVB
(270e320 nm, 7000 mW/cm2) irradiation ﬁve times every day, the
clinical symptoms of recurrent genital herpes were observed.
LDXGFG effects on the genital herpes guinea pig model
To understand the effects of LDXGFG on expression of TLR
pathway genes genital herpes guinea pig, LDXGFG or ACV feeding
was performed. The low, moderate, and high LDXGFG mice were
fed with 1 g/kg, 10 g/kg, and 20 g/kg LDXGFG, respectively. The ACV
group was fed with 25 mg/kg ACV. For each group, ﬁve individuals
were maintained. The treatment was performed once a day and the
guinea pigs were fed twice a day. The experiment lasted for 30 days.
After the experiment, the gene expression levels were detected by
real-time PCR.
Separation and differentiation of DCs
The DCs were generated following the previous study [21]. First,
peripheral blood mononuclear cells (PBMCs) were isolated from
jugular venous blood using lymphocytes separation medium by
Figure 3. Effects of Longdanxiegan formula granule (LDXGFG) on mRNA expression of Toll-like receptor (TLR) pathway genes in genital herpes and recurrent genital herpes guinea
pig in vulva by real-time polymerase chain reaction. Different letters show signiﬁcant difference between the control and genital herpes groups (p < 0.05).
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Sweden). After 2 hours, the adherent monocytes were cultured for
5 days in GM-CSF (500 U/mL; Gentaur, Brussels, Belgium), 20 ng/mL
of IL-4 and20ng/mLof tumornecrosis factor-a in serum-free CellGro
DC media (CellGenix, Heidelberg, German). After 5 days, the cells
were used for further studies. For dosage studies, the DCs were
randomly divided into four groups: control (with no LDXGFG treat-
ment); low LDXGFG (0.1nM); moderate LDXGFG (10nM); and high
LDXGFG (1000nM). All thegroupswere treated for24hours and then
the cells were collected for real-time PCR analysis. For time-
dependent study, the cells were divided into seven groups:
0 hours, 2 hours, 4 hours, 8 hours, 16 hours, 24 hours, 48 hours, and
96hours. The treatmentdosagewasmoderate LDXGFG(10nM).After
treatment, the mRNA expressionwas detected by real-time PCR.Separation of LCs
The LCs were derived following previous studies [21] and the
expression of phenotypic marker were characterized of the LCs. In
brief, the cells were ﬁrst isolated from infected tissues. Then the
cells were separated in Ficoll lymphocyte separation medium.
After density gradient equilibrium and centrifugation for
30 minutes at 3000 g/min, the cells at intermediate layer were
obtained. Subsequently, the cells were incubated by CD1a mono-
clonal antibody immunomagnetic beads at 4C for 20 minutes.
After washing with phosphate-buffered saline and magnetic cell
sorting, the LCs were isolated. The dosage- and time-dependent
studies of LDXGFG effect were performed according to the
studies in DCs.
Figure 4. Characteristics of dendritic cells (DCs). (A) Total number of DCs compared with blood monocytes control that were generated from 75  106 cells. (B) Viability (percentage
of FSC and CD11APCs) of DCs. C. Expression levels of DCs compared with blood monocytes control. Different letters show signiﬁcant difference between the control and genital
herpes groups (p < 0.05).
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Once the tissues and cells were collected from the guinea pigs,
they were stored at 80C until used. Total RNA were extracted
using Trizol reagent (Invitrogen, Carlsbad, CA, USA). The quantity
and quality of the RNA were assayed. After digestion with DNase I
(Fermentas, Vilnius, Lithuania) to eliminate residual DNA, the RNAs
were reverse transcripted to the ﬁrst strand cDNA by using Pri-
meScript One Step RT-PCR Kit version 2 (Takara, Dalian, China). The
primers of the studied gene were synthesized from previouspublished sequences [22,23]. The real-time PCR reactions were
carried out on Applied Biosystems 7500 Real-Time PCR system. The
PCR reaction condition was: 95C for 3 minutes followed by 40
cycles at 95C for 15 seconds and 60C for 40 seconds. Each sample
with the same primers was repeated three times. A melting curve
was obtained to conﬁrm if the ampliﬁcation products were speciﬁc.
The relative expression was calculated by ABI 7500 software
version 2.0.1 (Applied Biosystems, CA, USA) using the 2eDDCt
method.
Figure 5. Expression changes of Toll-like receptor (TLR) pathway genes in dendritic cells (DCs) after Longdanxiegan formula granule (LDXGFG) treatment. (A) Downregulated genes
in genital herpes (TLR1, TLR4, TLR6, TLR7, TLR8, TLR9, and TLR10) stimulated by LDXGFG in DCs. (B) Upregulated genes in genital herpes [TLR2, TLR3, TLR5, myeloid differentiation
primary response gene 88 (MyD88), and nuclear factor (NF)-kB] depressed by LDXGFG in DCs. (C) Time-dependent studies of downregulated genes after LDXGFG treatment in DCs.
(D) Time-dependent studies of upregulated genes after LDXGFG treatment in DCs.
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For immunohistochemical assay, 6-mmparafﬁn sectionswereﬁrst
prepared. Then the tissue sections were incubated with 10% H2O2 for
30 minutes and blocked with 10% normal calf serum (Invitrogen,
Carlsbad, CA, USA) for 1 hour at room temperature. The sectionswere
incubated with primary antibodies for 24 hours at 4C. All the pri-
mary antibodies were purchased from Santa Cruz Biotechnology
(Dallas, TX, USA; dilution 1:200). The signals were detected using
Histostain-Plus Bulk kit (Invitrogen) against rabbit immunoglobulin
G. 3,30-Diaminobenzidine was used to visualize the signals. The
sections were observed using an Olympus BX51 microscope
(Olympus, Tokyo, Japan) and the photos were taken using an
Olympus C-5050 digital camera (Olympus, Tokyo, Japan).
Flow cytometry
To analyze the cell activity and distinctive factors, the cells were
assayed by ﬂow cytometry. First, the cells were stimulated with
25 ng/mL PMA (SigmaeAldrich) at 37C for 4 hours. Then, for the
test, FITC-labeled CD11c, CD80, CD83, CD86, HLA-DR and HLA-ABC,
and Percp-cy5.5-labeled CD11APCwere incubated with the cells for20 minutes at 4C. After ﬁxing and permeabilization, the cells were
analyzed by an Epics XL-MCL ﬂow cytometer (Beckman Coulter,
Miami, FL, USA). The calculation was performed with EXPO32 ADC
software.
Statistical analysis
The data in the study are expressed as mean ± standard devi-
ation. All the statistical analysis was performed using SPSS 13.0
(SPSS Inc., Chicago, IL, USA). One-way analysis of variance (ANOVA)
was used to assay the signiﬁcant differences. A p value < 0.05 was
considered statistically signiﬁcant.
Results
TLR signaling pathway changes in recurrent genital herpes
The levels of TLR signaling pathway genes in recurrent genital
herpes guinea pigs were detected by real-time PCR. TLR1, TLR4,
TLR6, TLR7, TLR8, TLR9, and TLR10 decreased signiﬁcantly after
infecting with HSV2SAV as well as in recurrent genital herpes
guinea pigs. However, TLR2, TLR3, and TLR5 increased in genital
Figure 6. Characteristics of Langerhans cells (LCs). (A) Viability (percentage of FSC) of LCs. (B) Expression levels of LCs compared with unisolated cells control. Different letters show
signiﬁcant difference between the control and genital herpes groups (p < 0.05).
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differentiation primary response gene 88 (MyD88) and nuclear
factor (NF)-kB were upregulated in both genital herpes and recur-
rent genital herpes guinea pigs (Figure 1). The result indicated that
the genes could be assigned into two different groupsddecreased
group (TLR1, TLR4, TLR6, TLR7, TLR8, TLR9, and TLR10) and
increased group (TLR2, TLR3, TLR5, MyD88, and NF-kB)dindicating
different expression changes after HSV2 infection. The immuno-
histochemistry result also indicated the decreased TLR1 and TLR9
as well as increased MyD88 and NF-kB in genital herpes and
recurrent genital herpes guinea pigs (Figure 2).
LDXGFG effects on TLR signaling pathway in recurrent genital herpes
The effects of LDXGFG on TLR signaling pathway genes in genital
herpes and recurrent genital herpes guinea pigs were determined.
For TLR1, TLR4, TLR6, TLR7, TLR8, TLR9, and TLR10, the levels of
genes in pudendum tissues were increased signiﬁcantly with
LDXGFG or ACV feeding (Figure 3). By contrast, TLR2, TLR3, TLR5,
MyD88, and NF-kB levels decreased after LDXGFG or ACV feeding
(Figure 3). The moderate LDXGFG dosage was the most effective.
Thus, it can be concluded that 10 g/kg LDXGFG amount is the
optimal dosage for genital herpes guinea pigs. In addition, LDXGFG
showed similar effects with ACV in this study (Figure 3). These
results indicate different effects of LDXGFG and ACV on the
decreased group (TLR1, TLR4, TLR6, TLR7, TLR8, TLR9, and TLR10)
and increased group (TLR2, TLR3, TLR5, MyD88, and NF-kB) genes.
LDXGFG acts on TLR signaling pathway in DCs
We ﬁrst compared the characteristics of DCs differentiated in
culture cells to normal PBMCs as control. Signiﬁcant differences
between control (bloodmonocytes) and DCswere found both in the
yield of DCs (Figure 4A) and their viability (Figure 4B). The FSC/SSC
and CD11APC/SSC analysis showed that DCs were larger and more
granular than control cells. To determine the capacity of immatureDCs to be activated by TLR ligands, we evaluated the expression of
costimulatory molecules including CD11c, CD80, CD83, CD86,
HLA-DR, and HLA-ABC. All these costimulatory molecules increased
signiﬁcantly in DCs compared to normal PBMCs (Figure 4C).
After determining the effects of LDXGFG on the TLR signaling
pathway in recurrent genital herpes, we found that the factors of
TLR signaling pathway could divide into two different groups:
downregulated genes (TLR1, TLR4, TLR6, TLR7, TLR8, TLR9, and
TLR10) and upregulated genes in genital herpes (TLR2, TLR3, TLR5,
MyD88, and NF-kB). Meanwhile, the DCs were treated with
LDXGFG. The results suggest that the downregulated genes could
be stimulated by LDXGFG (Figure 5A) while the upregulated factors
were depressed by LDXGFG (Figure 5B). The moderate LDXGFG had
the best effects both in stimulation of the downregulated genes and
depression of upregulated genes. Time-dependent study showed
that LDXGFG had a long-term effect at least until 96 hours
(Figures 5C and 5D).
LDXGFG effects on TLR signaling pathway in LCs
LCs were identiﬁed by ﬂow cytometry. This showed that the
costimulatory molecules including CD11c, CD80, CD83, CD86, HLA-
DR, and HLA-ABC were highly expressed in LCs (Figure 6). The LCs
were treated by LDXGFG. All the downregulated genes in genital
herpes were stimulated after LDXGFG treatment in low, moderate,
and high dosages (Figure 7A) while all the upregulated genes in
genital herpes exhibited a decrease after LDXGFG treatment in all
the dosage groups (Figure 7B). In the time-dependent study, the
stimulation of downregulated genes and the depression of upre-
gulated genes in genital herpes both lasted until 96 hours
(Figures 7C and 7D).
Discussion
Several studies show abnormal expression of immune factors
mediated in HSV1 and HSV2 infected genital herpes. This research
Figure 7. Expression changes of Toll-like receptor (TLR) pathway genes in Langerhans cells (LCs) after Longdanxiegan formula granule (LDXGFG) treatment. (A) Downregulated
genes in genital herpes (TLR1, TLR4, TLR6, TLR7, TLR8, TLR9, and TLR10) stimulated by LDXGFG in LCs. (B) Upregulated genes in genital herpes [TLR2, TLR3, TLR5, myeloid dif-
ferentiation primary response gene 88 (MyD88), and nuclear factor (NF)-kB] depressed by LDXGFG in LCs. (C) Time-dependent studies of downregulated genes after LDXGFG
treatment in LCs. (D) Time-dependent studies of upregulated genes after LDXGFG treatment in LCs. Different letters show signiﬁcant difference between the control and genital
herpes groups (p < 0.05).
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[13,24e26]. Also, the immune expression changes and hormone-
triggered reproductive immunity in vertebrates have been stud-
ied in detail [27,28]. Several medicines which work against genital
herpes have been developed, such as valacyclovir, famciclovir, and
penciclovir [29]. These drugs also show effects on regulating the
immune system against the virus. However, due to the migration
and prolonging attribution of HSV in host, patients after treatment
with these drugs usually suffer from recurrent genital herpes. Ac-
cording to our clinical experience, a Chinese medicine, LDXGFG
shows a prolonged effect against HSV2 infected recurrent genital
herpes [18]. LDXGFG affects expression of several immune factors
such as proinﬂammatory cytokines. However, the mechanisms of
LDXGFG on recurrent genital herpes especially the effects TLR
pathway factors are still not clear.
First, we showed expression changes of TLR pathway factors in
genital herpes and recurrent genital herpes tissues. The results
showed the same expression pattern of TLR pathway factors in
genital herpes and recurrent genital herpes tissues. The analyzedgeneswere divided into twogroups by the expression changes. TLR1,
TLR4, TLR6, TLR7, TLR8, TLR9, and TLR10 were downregulated and
signiﬁcantly decreased after HSV2 infection, while TLR2, TLR3, TLR5,
MyD88, and NF-kB were upregulated groups and signiﬁcantly
increased in genital herpes and recurrent genital herpes tissues.
Studies into expression changes of TLR pathway factors after HSV2
infection are rare. Li and colleagues [22] reported that HSV2 stimu-
lated IL-1, IFN-b, TLR4, and TLR9 expression in cervical epithelial
cells, which is contradictory to the present ﬁnding. This may be due
to the different samples between these two studies. We used in vivo
guinea pigs while the previous study used in vitro cervical epithelial
cells. However, they concluded that HSV2 depressed TLR4 and TLR9
expression in guinea pigs as we found. TLR pathway factors are
enormous which contains several genes. Herein, we assayed 12
genes in this pathway. Thus, in thepresent study,we initially showed
a duality of TLR pathway factors in HSV2 infected genital herpes.
Furthermore, the LDXGFG effects on TLR pathway factors of
recurrent genital herpes were analyzed. The present result sug-
gested that TLR1, TLR4, TLR6, TLR7, TLR8, TLR9, and TLR10 showed a
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as one of the most common treatments for HSV2 infection, was
used in the present experiment. The downregulated genes in
genital herpes and recurrent genital herpes were stimulated by
LDXGFG, while the upregulated genes were signiﬁcantly decreased
after LDXGFG treatment. In total, the result showed that LDXGFG
corrected the abnormal expression of TLR pathway genes, and
provided a probable therapy for HSV infection. Meanwhile, the
details of expression information on themechanism and location of
TLR pathway genes needs to be elucidated.
DCs are the strongest antigen-presenting cells in mammalian
immune systems [26]. The DCs is differentiated from blood
monocytes and could be induced by colony stimulating factor, IL-4
and tumor necrosis factor-a. In the present studies, we differenti-
ated the DCs from peripheral blood mononuclear cells. The ﬂow
cytometry analysis determined that all the tested costimulatory
molecules are highly expressed in DCs. After treatment with
LDXGFG, the expression of TLR pathway genes was changed, which
was similar to the genes in recurrent genital herpes. The down-
regulated genes and the upregulated genes in genital herpes were
stimulated and depressed by LDXGFG treatment, respectively. In
addition, LCs were isolated from infected tissues and the TLR
pathway changes were also detected. Similarly, in LCs, the TLR
pathway genes exhibited same of LDXGFG correcting the abnormal
expression of TLR pathway genes. Here, we found that the effects of
LDXGFG last at least 96 hours both in DCs and LCs, which demon-
strates the long-term effect of this medicine.
Nowadays, traditional Chinesemedicine, as a healthcaremedical
system provides a different insight into immune response and
treatment therapy. LDXGFG, which consists of 10 different in-
gredients, regulates immune factors, including proinﬂammatory
cytokines and TLR pathwaygenes. In our present study, we reported
the rescue of LDXGFGon abnormal expression of TLR pathwaygenes
after HSV2 infection, which is mediated by DCs in peripheral blood
and LCs in infected tissues. Meanwhile, the present study suggests
LDXGFG as an alternative, inexpensive, and lasting-effect medicine
for curing HSV2 infection caused genital herpes.
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